RS-1439

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRS-1439
Drug Alias NameRS-1439
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsSerotonin reuptake inhibitors
TargetsAcetylcholinesteraseSerotonin transporter
Therapy Area/IndicationsDepressionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressionAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A